People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vuja De Sciences, Inc. | — | Other | Seed | $4.4M | $1.4M | 2022 |
| Helocyte, Inc. | — | Biotechnology | Seed | $4.0M | $177.5M | 2016 |
Frank Taffy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank Taffy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lindsay A. Rosenwald | 1 | 7 |
| Michael S. Weiss | 1 | 7 |
| DAVID J. HORIN | 1 | 4 |
| Robert Hurst | 1 | 3 |
| Kenneth W. Cappell | 1 | 2 |
| David Warshawsky | 1 | 1 |
| Lee Helman | 1 | 1 |
| Carl Barrett | 1 | 1 |
| Chand Khanna | 1 | 1 |
| Richard Lampe | 1 | 1 |
| Elizabeth Clark Moore | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.